Maryland Oncology Hematology remains open while making accommodations for the health and safety of our patients. If you believe you have been exposed to COVID-19 or have symptoms of COVID-19 including fever, cough, sore throat or shortness of breath, please call our office before you arrive. Our Wheaton, Germantown (reopening 6/15) and Mt. Airy locations remain temporarily closed. View more information.


Frederick Min, M.D.

Frederick Min, M.D.


Medical Oncology


Silver Spring
12210 Plum Orchard Dr #211 Silver Spring, MD 20904
Phone: 301-933-3216
Fax: 832-601-6868
View Map



Frederick Min, M.D.


Clinical Pharmacology & Oncology from NIH and Georgetown University Medical Center


Dr. Frederick Min has extensive experience as a clinical investigator and drug developer. After his internal medicine training from Cornell, he proceeded to combined Clinical Pharmacology and Oncology fellowship from NIH and Georgetown University Medical Center. He has published and presented over 20 abstracts and articles in ASCO, ASH, ASCPT and FDA meetings. He has led several Phase I clinical trials as clinical investigator during the fellowship including the recently approved Treanda (Bendamustine). Most recently, he lead 5 novel therapies in different stages in the US, Europe and Asia as Global Project Leader at Novartis as Medical Director. There he also served as a committee member in Target Identification Committee which is a global initiative project to identify critical novel targets with the goal of personalized medicine. With his extensive experience as a clinical investigator and drug developer, we believe he will bring our patients the most up to date and advanced therapies available. He is fluent in Korean.

Dr. Min was recently honored with the Rises award from Washington Adventist Hospital, and was named one of “America’s Top Oncologists” for 2010 by the Consumers’ Research Council of America.